We present the debriefing of this highly interesting meeting for BÜHLMANN diagnostic products. Numerous ECCO IBD abstracts contained data produced by BÜHLMANN assays, mainly calprotectin and biologics trough levels by Quantum Blue® and by the IBDoc® home test.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US.
This describes the innovative aspect that test results can be acted on more quickly than waiting for standard laboratory tests and could help reduce colonoscopies and clinical appointments.
An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access.
Social Links